Amaurosis fugax
Amaurosis fugax is transient, painless monocular vision loss from retinal ischemia, most often microembolic from an ipsilateral carotid or a cardiac source, and it is treated as a TIA-equivalent with urgent carotid/cardiac workup and immediate aspirin 81 mg daily plus a high-intensity statin.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Definition: sudden, painless, transient monocular vision loss from temporary retinal ischemia, classically a curtain or shade descending over one eye that resolves completely within minutes.
- Epidemiology
Age and risk-factor overlap: occurs mainly over age 60, more common in men, with the atherosclerotic risk factors (hypertension, diabetes, hyperlipidemia, smoking) that drive ischemic stroke and TIA generally.
- Risk factors
Carotid atherosclerosis, age over 60 years: the dominant risk factor; risk rises with stenosis grade, substantial at 50% to 70% and highest above 70%.
- Pathophysiology
Embolic occlusion of the retinal circulation: a platelet-fibrin or cholesterol embolus, or less often a calcific valvular embolus, lodges in the central retinal artery or a branch, transiently interrupting flow.
- Clinical features
Sudden, painless, monocular vision loss: the hallmark; a curtain, shade, or gray-out over part or all of one eye's field, without pain.
- Differential diagnosis
Giant cell arteritis: transient or progressive loss with headache, scalp tenderness, jaw claudication, fever over age 50; discriminated by elevated ESR (typically 50 mm/h) and CRP, and threatens permanent, bilateral loss.
- Diagnosis
This is a clinical diagnosis established by history: sudden, painless, transient monocular vision loss lasting seconds to under an hour with complete resolution and a normal interval eye exam.
- Management
Treat as an emergency, urgent evaluation before discharge: same-day carotid imaging and cardiac assessment, because stroke risk is highest in the first 48 hours after a TIA; admission or an…
- Complications
Ischemic stroke: the principal risk; untreated patients face the same short-term stroke risk as any other TIA, concentrated in the first 48 hours to 90 days.
- Prognosis
Stroke risk mirrors TIA: highest in the first 48 hours and through 90 days, which is why urgent workup and immediate secondary prevention change outcomes.
- Prevention
Aspirin 81 mg PO once daily, continued indefinitely, for any history of amaurosis fugax or other atherosclerotic vascular event, as first-line secondary prevention.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Central retinal artery occlusion
Central retinal artery occlusion is sudden, painless, profound monocular vision loss from embolic or thrombotic occlusion of the central retinal artery, an ocular stroke equivalent in which irreversible retinal infarction begins around 90 minutes after complete occlusion. Diagnosis is clinical on dilated fundoscopy, and management pairs time-critical reperfusion attempts with an emergency embolic and giant-cell-arteritis workup to protect the fellow eye and prevent a subsequent stroke.
- Carotid artery stenosis
Carotid artery stenosis is atherosclerotic narrowing of the extracranial internal carotid artery that raises ischemic stroke risk, graded by percent luminal narrowing on duplex ultrasound. Symptomatic stenosis of at least 50% warrants urgent revascularization; asymptomatic stenosis under 80% is managed with best medical therapy alone, including a high-intensity statin and antiplatelet agent.
- Ischemic stroke
Ischemic stroke is sudden focal neurologic deficit from arterial occlusion confirmed by infarction on neuroimaging. Diagnosis relies on urgent noncontrast head CT to exclude hemorrhage; treatment is IV alteplase within 4.5 hours and mechanical thrombectomy for large-vessel occlusion within an extended window, followed by antiplatelet therapy and risk-factor control.
- Atrial fibrillation
Atrial fibrillation is a supraventricular tachyarrhythmia with disorganized atrial activation and an irregularly irregular ventricular response, the most common sustained arrhythmia and a major cause of stroke. Diagnosis is by ECG showing no discrete P waves with irregular RR intervals, and management addresses rate or rhythm control, stroke prevention by CHA2DS2-VASc-guided anticoagulation, and the underlying cause.
- Giant cell arteritis
Giant cell arteritis is a granulomatous large- and medium-vessel vasculitis of patients over 50 that threatens irreversible blindness through ischemic optic neuropathy. Diagnosis is clinical and must not delay treatment: start high-dose glucocorticoids immediately on suspicion, intravenous methylprednisolone pulse for visual loss, then confirm with temporal artery biopsy within 1 to 2 weeks and add tocilizumab as glucocorticoid-sparing therapy.
- Carotid artery dissection
Carotid artery dissection is a tear in the wall of the internal carotid artery creating an intramural hematoma, typically presenting with unilateral head, face, or neck pain, partial Horner syndrome, and ischemic stroke or transient ischemic attack in a young or middle-aged patient. Diagnosis is by MRA or CTA of the neck, and most patients are treated with antiplatelet or anticoagulant therapy.
- Optic neuritis
Optic neuritis is inflammatory demyelination of the optic nerve, usually a presenting event of multiple sclerosis, causing subacute painful monocular vision loss with a relative afferent pupillary defect. Confirm with MRI orbits/brain and treat with IV methylprednisolone followed by an oral prednisone taper, never oral prednisone alone.
- Acute angle-closure glaucoma
Acute angle-closure glaucoma is a pupillary-block emergency in which sudden closure of the iridocorneal angle blocks aqueous outflow, causing severe eye pain, halos, and rapidly rising intraocular pressure that can blind the eye within hours if not treated. Diagnosis is clinical plus tonometry and gonioscopy; treatment is immediate topical and systemic IOP-lowering therapy followed by laser peripheral iridotomy.
- Migraine headache
Migraine is a primary episodic headache disorder diagnosed by ICHD-3 clinical criteria (recurrent attacks, 4-72 hours, pulsatile/unilateral pain with nausea or photophobia/phonophobia). First-line acute treatment is an NSAID or oral triptan started early in the attack; prevention with a beta-blocker, topiramate, or CGRP-targeted therapy is added once attacks are frequent or disabling.
- Antiphospholipid syndrome
Antiphospholipid syndrome is an acquired autoimmune thrombophilia in which antiphospholipid antibodies cause recurrent venous and arterial thrombosis and pregnancy morbidity, paradoxically prolonging the aPTT in vitro while promoting clotting in vivo. Diagnosis requires a qualifying clinical event plus a laboratory antibody confirmed positive on two occasions at least 12 weeks apart, and thrombotic disease is treated with indefinite warfarin rather than a DOAC.
- Infective endocarditis
Infective endocarditis is microbial infection of the endocardium, usually a heart valve, producing vegetations that cause valve destruction, embolism, and systemic infection. Diagnosis uses the modified Duke criteria combining blood cultures and echocardiography, and treatment is prolonged targeted intravenous antibiotics with surgery for complications.